Dako A/S (Acquired by Agilent Technologies, Inc.)

57 articles about Dako A/S (Acquired by Agilent Technologies, Inc.)

• Agilent Launches New Panel For Fast FISH Testing On Dako Omnis In Lung Cancer

  9/22/2016

• Dako, an Agilent Technologies Inc. Company, Announces Expanded Use Of PD-L1 Diagnostic Test In Europe

  5/12/2016

• Dako, An Agilent Company, Announces Availability Of New Lung Cancer Test In Europe

  4/7/2016

• Quest Diagnostics Expands Dako's PD-L1 IHC 28-8 Complementary Test To Include Melanoma

  1/25/2016

• Dako Snags Expanded FDA Approval of Complementary Diagnostic Test to Include Melanoma

  1/25/2016

• Quest Diagnostics Introduces Dako's PD-L1 Complementary Diagnostic Test To Support Bristol-Myers Squibb's OPDIVO Anti-PD-1 Therapy For Non-Squamous Non-Small Cell Lung Cancer

  10/12/2015

• Dako, An Agilent Company, Announces FDA Approval Of New Test For Lung Cancer Patients

  10/12/2015

• Quest Diagnostics Introduces Dako's PD-L1 Companion Diagnostic For KEYTRUDA, Merck & Co.'s Anti-PD-1 Therapy For Metastatic Non-Small Cell Lung Cancer Whose Tumors Express PD-L1 With Disease Progression On Or After Platinum-Containing Chemotherapy

  10/5/2015

• Dako Snags FDA Approval of New Companion Diagnostic for Lung Cancer

  10/5/2015

• Dako Strikes Avelumab Pact with Pharma Giants Pfizer and Merck & Co.

  9/25/2015

• Dako A/S (Acquired by Agilent Technologies, Inc.) And Ono Pharmaceutical Company, Ltd. Announce Collaboration On Development Of PD-L1 Companion Diagnostic Test For Investigational Cancer Drug Opdivo(Nivolumab)

  2/16/2015

• Dako A/S (Acquired by Agilent Technologies, Inc.) And Cell Signaling Technology Announce Partnership Within Companion Diagnostics

  1/12/2015

• Dako A/S (Acquired by Agilent Technologies, Inc.) Launches Fast HER2 ISH Assay For New Automated Staining Platform In Europe

  9/2/2014

• New White Paper By Propath Supports Superiority Of Dako A/S (Acquired by Agilent Technologies, Inc.)'s HER2 IQFISH Pharmdx™ Kit

  7/7/2014

• Dako A/S (Acquired by Agilent Technologies, Inc.) And U.S.-Based Merck & Co., Inc. To Collaborate On Companion Diagnostic Test For Analysis Of Tumor PD-L1 Levels

  5/30/2014

• Dako A/S (Acquired by Agilent Technologies, Inc.), An Agilent Technologies, Inc. (Santa Clara, California) Company, Launches Two Ready-To-Use Antibodies For Cancer Diagnosis

  5/2/2014

• Dako A/S (Acquired by Agilent Technologies, Inc.) Further Expands World's Leading Special Stain Solution For Cancer Diagnostics

  2/28/2014

• Dako A/S (Acquired by Agilent Technologies, Inc.) And Amgen Expand Collaboration With Plan To Develop New Diagnostic Test

  2/11/2014

• Dako A/S (Acquired by Agilent Technologies, Inc.) To Collaborate With Merck & Co., Inc. On Development Of Companion Diagnostics For Cancer Treatment

  1/9/2014

• Dako A/S (Acquired by Agilent Technologies, Inc.) Publishes Sixth Edition Of Immunohistochemistry Guidebook

  12/12/2013